Improving Outcomes in CTD-PAH: Diagnosis, Treatment & Multidisciplinary Care
| Overview / Abstract: |
In this interview-style eNewsletter, Dr. Dinesh Khanna and Dr. Victor Tapson share ways to improve the recognition and diagnosis of CTD-PAH. Through discussions on the role of screening and a review of current and emerging therapies, our faculty provide context to creating a personalized treatment approach that highlights the importance of increasing communication across a multidisciplinary team. Given the impact on patient outcomes, screening of PAH in CTD patients is of critical importance. The purpose of this activity is to enhance clinician skills in the recognition and diagnosis of CTD-PAH in order to provide effective treatment within a multidisciplinary team. Faculty provide practical guidance on screening tools and effective therapies to enable clinicians to improve patient care. |
|
Expiration |
Dec 18, 2021 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Respiratory Therapy CE |
|
Format |
Online |
|
Credits / Hours |
.50 AMA PRA Category 1 Credit(s)™ |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
Dinesh Khanna, MD, MSc; Victor Tapson, MD |
|
Activity Specialities / Related Topics |
Family Medicine, Internal Medicine, Primary Care, Pulmonary Medicine / COPD, Rheumatology / Arthritis |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals, and Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson. |
|
Keywords / Search Terms |
ACHL Free CE CME |
|